Application Sponsors
ANDA 212602 | INVAGEN PHARMS | |
Marketing Status
Application Products
001 | TABLET;ORAL | 625MG | 0 | COLESEVELAM HYDROCHLORIDE | COLESEVELAM HYDROCHLORIDE |
FDA Submissions
UNKNOWN; | ORIG | 1 | AP | 2020-04-20 | STANDARD |
Submissions Property Types
TE Codes
CDER Filings
INVAGEN PHARMS
cder:Array
(
[0] => Array
(
[ApplNo] => 212602
[companyName] => INVAGEN PHARMS
[docInserts] => ["",""]
[products] => [{"drugName":"COLESEVELAM HYDROCHLORIDE","activeIngredients":"COLESEVELAM HYDROCHLORIDE","strength":"625MG","dosageForm":"TABLET;ORAL","marketingStatus":"Discontinued","te":"None","rld":"No","rs":"No"}]
[labels] =>
[originalApprovals] => [{"actionDate":"04\/20\/2020","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
[supplements] =>
[actionDate] => 2020-04-20
)
)